PDB Short entry for 1WUT HEADER TRANSFERASE 08-DEC-04 1WUT TITLE ACYL UREAS AS HUMAN LIVER GLYCOGEN PHOSPHORYLASE INHIBITORS FOR THE TITLE 2 TREATMENT OF TYPE 2 DIABETES COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCOGEN PHOSPHORYLASE, MUSCLE FORM; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MYOPHOSPHORYLASE; COMPND 5 EC: 2.4.1.1 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ORYCTOLAGUS CUNICULUS; SOURCE 3 ORGANISM_COMMON: RABBIT; SOURCE 4 ORGANISM_TAXID: 9986; SOURCE 5 TISSUE: MUSCLE KEYWDS GLYCOGENOLYSIS, TYPE 2 DIABETES, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR T.KLABUNDE,K.U.WENDT,D.KADEREIT,V.BRACHVOGEL,H.-J.BURGER,A.W.HERLING, AUTHOR 2 N.G.OIKONOMAKOS,M.N.KOSMOPOULOU,D.SCHMOLL,E.SARUBBI,E.VON ROEDERN, AUTHOR 3 K.SCHONAFINGER,E.DEFOSSA REVDAT 3 13-JUL-11 1WUT 1 VERSN REVDAT 2 24-FEB-09 1WUT 1 VERSN REVDAT 1 08-DEC-05 1WUT 0 JRNL AUTH N.G.OIKONOMAKOS,M.N.KOSMOPOULOU,E.D.CHRYSINA,D.D.LEONIDAS, JRNL AUTH 2 I.D.KOSTAS,K.U.WENDT,T.KLABUNDE,E.DEFOSSA JRNL TITL CRYSTALLOGRAPHIC STUDIES ON ACYL UREAS, A NEW CLASS OF JRNL TITL 2 GLYCOGEN PHOSPHORYLASE INHIBITORS, AS POTENTIAL ANTIDIABETIC JRNL TITL 3 DRUGS JRNL REF PROTEIN SCI. V. 14 1760 2005 JRNL REFN ISSN 0961-8368 JRNL PMID 15987904 JRNL DOI 10.1110/PS.051432405 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH N.G.OIKONOMAKOS,V.T.SKAMNAKI,K.E.TSITSANOU,N.G.GAVALAS, REMARK 1 AUTH 2 L.N.JOHNSON REMARK 1 TITL A NEW ALLOSTERIC SITE IN GLYCOGEN PHOSPHORYLASE B AS A REMARK 1 TITL 2 TARGET FOR DRUG INTERACTIONS REMARK 1 REF STRUCTURE FOLD.DES. V. 8 575 2000 REMARK 1 REFN ISSN 0969-2126 REMARK 1 PMID 10873856 REMARK 1 DOI 10.1016/S0969-2126(00)00144-1 REMARK 1 REFERENCE 2 REMARK 1 AUTH S.E.ZOGRAPHOS,N.G.OIKONOMAKOS,K.E.TSITSANOU,D.D.LEONIDAS, REMARK 1 AUTH 2 E.D.CHRYSINA,V.T.SKAMNAKI,H.BISCHOFF,S.GOLDMANN,K.A.WATSON, REMARK 1 AUTH 3 L.N.JOHNSON REMARK 1 TITL THE STRUCTURE OF GLYCOGEN PHOSPHORYLASE B WITH AN REMARK 1 TITL 2 ALKYLDIHYDROPYRIDINE-DICARBOXYLIC ACID COMPOUND, A NOVEL AND REMARK 1 TITL 3 POTENT INHIBITOR REMARK 1 REF STRUCTURE V. 5 1413 1997 REMARK 1 REFN ISSN 0969-2126 REMARK 1 PMID 9384557 REMARK 1 DOI 10.1016/S0969-2126(97)00292-X REMARK 1 REFERENCE 3 REMARK 1 AUTH V.L.RATH,M.AMMIRATI,D.E.DANLEY,J.L.EKSTROM,E.M.GIBBS, REMARK 1 AUTH 2 T.R.HYNES,A.M.MATHIOWETZ,R.K.MCPHERSON,T.V.OLSON, REMARK 1 AUTH 3 J.L.TREADWAY,D.J.HOOVER REMARK 1 TITL HUMAN LIVER GLYCOGEN PHOSPHORYLASE INHIBITORS BIND AT A NEW REMARK 1 TITL 2 ALLOSTERIC SITE REMARK 1 REF CHEM.BIOL. V. 7 677 2000 REMARK 1 REFN ISSN 1074-5521 REMARK 1 PMID 10980448 REMARK 1 DOI 10.1016/S1074-5521(00)00004-1 REMARK 1 REFERENCE 4 REMARK 1 AUTH Z.LU,J.BOHN,R.BERGERON,Q.DENG,K.P.ELLSWORTH,W.M.GEISSLER, REMARK 1 AUTH 2 G.HARRIS,P.E.MCCANN,B.MCKEEVER,R.W.MYERS,R.SAPERSTEIN, REMARK 1 AUTH 3 C.A.WILLOUGHBY,J.YAO,K.CHAPMAN REMARK 1 TITL A NEW CLASS OF GLYCOGEN PHOSPHORYLASE INHIBITORS REMARK 1 REF BIOORG.MED.CHEM.LETT. V. 13 4125 2003 REMARK 1 REFN ISSN 0960-894X REMARK 1 PMID 14592521 REMARK 1 DOI 10.1016/J.BMCL.2003.08.046 REMARK 2 REMARK 2 RESOLUTION. 2.26 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.26 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.49 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0010 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.7 REMARK 3 NUMBER OF REFLECTIONS : 44138 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2248 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.26 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.40 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6607 REMARK 3 BIN R VALUE (WORKING SET) : 0.2740 REMARK 3 BIN FREE R VALUE : 0.2960 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 380 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.015 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6634 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 240 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM SIGMAA (A) : 0.28 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.29 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.40 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.75 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.220 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.150 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.880 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.050 ; 2.500 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : BNP.PARAM REMARK 3 PARAMETER FILE 3 : PLP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : BNP.TOP REMARK 3 TOPOLOGY FILE 3 : PLP.TOP REMARK 3 TOPOLOGY FILE 4 : WATER.TOP REMARK 3 TOPOLOGY FILE 5 : LYSH.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 1WUT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 14-DEC-04. REMARK 100 THE RCSB ID CODE IS RCSB024025. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-OCT-00 REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 6.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44163 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.260 REMARK 200 RESOLUTION RANGE LOW (A) : 29.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.7 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.26 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.6 REMARK 200 DATA REDUNDANCY IN SHELL : 5.40 REMARK 200 R MERGE FOR SHELL (I) : 0.24800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.91 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10MM BES BUFFER, 3MM DDT, PH 6.7, REMARK 280 SMALL TUBES, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.98850 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 64.33950 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 64.33950 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 86.98275 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 64.33950 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 64.33950 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 28.99425 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 64.33950 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 64.33950 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 86.98275 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 64.33950 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 64.33950 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 28.99425 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 57.98850 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: DIMERIC GLYCOGEN PHOSPHORYLASE IS THE PHYSIOLOGIACALLY REMARK 300 ACTIVE SPECIES REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 7560 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 57270 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -48.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 115.97700 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1 REMARK 465 ARG A 2 REMARK 465 PRO A 3 REMARK 465 LEU A 4 REMARK 465 SER A 5 REMARK 465 ASP A 6 REMARK 465 GLN A 7 REMARK 465 GLU A 8 REMARK 465 LYS A 9 REMARK 465 ARG A 10 REMARK 465 LYS A 11 REMARK 465 GLN A 12 REMARK 465 LYS A 315 REMARK 465 PHE A 316 REMARK 465 GLY A 317 REMARK 465 CYS A 318 REMARK 465 ARG A 319 REMARK 465 ASP A 320 REMARK 465 PRO A 321 REMARK 465 VAL A 322 REMARK 465 ARG A 323 REMARK 465 ASP A 838 REMARK 465 GLU A 839 REMARK 465 LYS A 840 REMARK 465 ILE A 841 REMARK 465 PRO A 842 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 CA ASN A 44 O4 BN2 A 930 7556 1.87 REMARK 500 CB ASN A 44 O4 BN2 A 930 7556 2.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 63 CA - CB - CG ANGL. DEV. = 14.0 DEGREES REMARK 500 LYS A 554 N - CA - C ANGL. DEV. = 17.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 14 -156.87 -64.01 REMARK 500 VAL A 15 50.37 -98.81 REMARK 500 ALA A 19 66.43 -107.19 REMARK 500 ARG A 43 -29.51 -36.14 REMARK 500 LEU A 131 42.86 -86.69 REMARK 500 PRO A 194 20.30 -74.87 REMARK 500 TYR A 203 -129.71 62.88 REMARK 500 ASP A 251 -102.92 -79.11 REMARK 500 PHE A 252 -36.25 -39.75 REMARK 500 LEU A 254 -41.18 164.22 REMARK 500 ASN A 258 65.66 95.07 REMARK 500 VAL A 259 146.51 62.26 REMARK 500 LEU A 271 -39.29 -158.94 REMARK 500 PRO A 281 25.99 -76.11 REMARK 500 SER A 313 -73.45 -84.18 REMARK 500 ASP A 339 -168.41 79.41 REMARK 500 ALA A 435 -71.65 -35.15 REMARK 500 THR A 466 -97.05 -114.47 REMARK 500 LEU A 492 -74.84 -151.49 REMARK 500 ASP A 514 63.67 -155.93 REMARK 500 LYS A 554 101.51 55.72 REMARK 500 VAL A 555 37.21 160.26 REMARK 500 HIS A 556 145.33 37.76 REMARK 500 LYS A 568 170.43 177.85 REMARK 500 ILE A 666 41.36 -107.59 REMARK 500 SER A 674 -63.25 -146.67 REMARK 500 PHE A 709 77.77 -106.36 REMARK 500 HIS A 768 52.49 -140.42 REMARK 500 LYS A 772 65.68 30.38 REMARK 500 ILE A 824 -50.09 -125.82 REMARK 500 ARG A 831 34.99 -97.27 REMARK 500 PRO A 835 72.43 -50.54 REMARK 500 ALA A 836 170.82 47.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 ASN A 44 23.0 L L OUTSIDE RANGE REMARK 500 LYS A 554 23.6 L L OUTSIDE RANGE REMARK 500 VAL A 555 24.0 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PLP A 999 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BN2 A 930 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1C50 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH CP320626 REMARK 900 RELATED ID: 1WUY RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITH BN3 REMARK 900 RELATED ID: 1WV0 RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITH BN4 REMARK 900 RELATED ID: 1WV1 RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITH BN5 DBREF 1WUT A 1 842 UNP P00489 PHS2_RABIT 1 842 SEQADV 1WUT ILE A 380 UNP P00489 LEU 380 CONFLICT SEQRES 1 A 842 SER ARG PRO LEU SER ASP GLN GLU LYS ARG LYS GLN ILE SEQRES 2 A 842 SER VAL ARG GLY LEU ALA GLY VAL GLU ASN VAL THR GLU SEQRES 3 A 842 LEU LYS LYS ASN PHE ASN ARG HIS LEU HIS PHE THR LEU SEQRES 4 A 842 VAL LYS ASP ARG ASN VAL ALA THR PRO ARG ASP TYR TYR SEQRES 5 A 842 PHE ALA LEU ALA HIS THR VAL ARG ASP HIS LEU VAL GLY SEQRES 6 A 842 ARG TRP ILE ARG THR GLN GLN HIS TYR TYR GLU LYS ASP SEQRES 7 A 842 PRO LYS ARG ILE TYR TYR LEU SER LEU GLU PHE TYR MET SEQRES 8 A 842 GLY ARG THR LEU GLN ASN THR MET VAL ASN LEU ALA LEU SEQRES 9 A 842 GLU ASN ALA CYS ASP GLU ALA THR TYR GLN LEU GLY LEU SEQRES 10 A 842 ASP MET GLU GLU LEU GLU GLU ILE GLU GLU ASP ALA GLY SEQRES 11 A 842 LEU GLY ASN GLY GLY LEU GLY ARG LEU ALA ALA CYS PHE SEQRES 12 A 842 LEU ASP SER MET ALA THR LEU GLY LEU ALA ALA TYR GLY SEQRES 13 A 842 TYR GLY ILE ARG TYR GLU PHE GLY ILE PHE ASN GLN LYS SEQRES 14 A 842 ILE CYS GLY GLY TRP GLN MET GLU GLU ALA ASP ASP TRP SEQRES 15 A 842 LEU ARG TYR GLY ASN PRO TRP GLU LYS ALA ARG PRO GLU SEQRES 16 A 842 PHE THR LEU PRO VAL HIS PHE TYR GLY ARG VAL GLU HIS SEQRES 17 A 842 THR SER GLN GLY ALA LYS TRP VAL ASP THR GLN VAL VAL SEQRES 18 A 842 LEU ALA MET PRO TYR ASP THR PRO VAL PRO GLY TYR ARG SEQRES 19 A 842 ASN ASN VAL VAL ASN THR MET ARG LEU TRP SER ALA LYS SEQRES 20 A 842 ALA PRO ASN ASP PHE ASN LEU LYS ASP PHE ASN VAL GLY SEQRES 21 A 842 GLY TYR ILE GLN ALA VAL LEU ASP ARG ASN LEU ALA GLU SEQRES 22 A 842 ASN ILE SER ARG VAL LEU TYR PRO ASN ASP ASN PHE PHE SEQRES 23 A 842 GLU GLY LYS GLU LEU ARG LEU LYS GLN GLU TYR PHE VAL SEQRES 24 A 842 VAL ALA ALA THR LEU GLN ASP ILE ILE ARG ARG PHE LYS SEQRES 25 A 842 SER SER LYS PHE GLY CYS ARG ASP PRO VAL ARG THR ASN SEQRES 26 A 842 PHE ASP ALA PHE PRO ASP LYS VAL ALA ILE GLN LEU ASN SEQRES 27 A 842 ASP THR HIS PRO SER LEU ALA ILE PRO GLU LEU MET ARG SEQRES 28 A 842 VAL LEU VAL ASP LEU GLU ARG LEU ASP TRP ASP LYS ALA SEQRES 29 A 842 TRP GLU VAL THR VAL LYS THR CYS ALA TYR THR ASN HIS SEQRES 30 A 842 THR VAL ILE PRO GLU ALA LEU GLU ARG TRP PRO VAL HIS SEQRES 31 A 842 LEU LEU GLU THR LEU LEU PRO ARG HIS LEU GLN ILE ILE SEQRES 32 A 842 TYR GLU ILE ASN GLN ARG PHE LEU ASN ARG VAL ALA ALA SEQRES 33 A 842 ALA PHE PRO GLY ASP VAL ASP ARG LEU ARG ARG MET SER SEQRES 34 A 842 LEU VAL GLU GLU GLY ALA VAL LYS ARG ILE ASN MET ALA SEQRES 35 A 842 HIS LEU CYS ILE ALA GLY SER HIS ALA VAL ASN GLY VAL SEQRES 36 A 842 ALA ARG ILE HIS SER GLU ILE LEU LYS LYS THR ILE PHE SEQRES 37 A 842 LYS ASP PHE TYR GLU LEU GLU PRO HIS LYS PHE GLN ASN SEQRES 38 A 842 LYS THR ASN GLY ILE THR PRO ARG ARG TRP LEU VAL LEU SEQRES 39 A 842 CYS ASN PRO GLY LEU ALA GLU ILE ILE ALA GLU ARG ILE SEQRES 40 A 842 GLY GLU GLU TYR ILE SER ASP LEU ASP GLN LEU ARG LYS SEQRES 41 A 842 LEU LEU SER TYR VAL ASP ASP GLU ALA PHE ILE ARG ASP SEQRES 42 A 842 VAL ALA LYS VAL LYS GLN GLU ASN LYS LEU LYS PHE ALA SEQRES 43 A 842 ALA TYR LEU GLU ARG GLU TYR LYS VAL HIS ILE ASN PRO SEQRES 44 A 842 ASN SER LEU PHE ASP VAL GLN VAL LYS ARG ILE HIS GLU SEQRES 45 A 842 TYR LYS ARG GLN LEU LEU ASN CYS LEU HIS VAL ILE THR SEQRES 46 A 842 LEU TYR ASN ARG ILE LYS LYS GLU PRO ASN LYS PHE VAL SEQRES 47 A 842 VAL PRO ARG THR VAL MET ILE GLY GLY LYS ALA ALA PRO SEQRES 48 A 842 GLY TYR HIS MET ALA LYS MET ILE ILE LYS LEU ILE THR SEQRES 49 A 842 ALA ILE GLY ASP VAL VAL ASN HIS ASP PRO VAL VAL GLY SEQRES 50 A 842 ASP ARG LEU ARG VAL ILE PHE LEU GLU ASN TYR ARG VAL SEQRES 51 A 842 SER LEU ALA GLU LYS VAL ILE PRO ALA ALA ASP LEU SER SEQRES 52 A 842 GLU GLN ILE SER THR ALA GLY THR GLU ALA SER GLY THR SEQRES 53 A 842 GLY ASN MET LYS PHE MET LEU ASN GLY ALA LEU THR ILE SEQRES 54 A 842 GLY THR MET ASP GLY ALA ASN VAL GLU MET ALA GLU GLU SEQRES 55 A 842 ALA GLY GLU GLU ASN PHE PHE ILE PHE GLY MET ARG VAL SEQRES 56 A 842 GLU ASP VAL ASP ARG LEU ASP GLN ARG GLY TYR ASN ALA SEQRES 57 A 842 GLN GLU TYR TYR ASP ARG ILE PRO GLU LEU ARG GLN ILE SEQRES 58 A 842 ILE GLU GLN LEU SER SER GLY PHE PHE SER PRO LYS GLN SEQRES 59 A 842 PRO ASP LEU PHE LYS ASP ILE VAL ASN MET LEU MET HIS SEQRES 60 A 842 HIS ASP ARG PHE LYS VAL PHE ALA ASP TYR GLU GLU TYR SEQRES 61 A 842 VAL LYS CYS GLN GLU ARG VAL SER ALA LEU TYR LYS ASN SEQRES 62 A 842 PRO ARG GLU TRP THR ARG MET VAL ILE ARG ASN ILE ALA SEQRES 63 A 842 THR SER GLY LYS PHE SER SER ASP ARG THR ILE ALA GLN SEQRES 64 A 842 TYR ALA ARG GLU ILE TRP GLY VAL GLU PRO SER ARG GLN SEQRES 65 A 842 ARG LEU PRO ALA PRO ASP GLU LYS ILE PRO HET PLP A 999 15 HET BN2 A 930 31 HETNAM PLP PYRIDOXAL-5'-PHOSPHATE HETNAM BN2 7-[2,6-DICHLORO-4-({[(2-CHLOROBENZOYL) HETNAM 2 BN2 AMINO]CARBONYL}AMINO)PHENOXY]HEPTANOIC ACID HETSYN PLP VITAMIN B6 PHOSPHATE HETSYN BN2 7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]- HETSYN 2 BN2 PHENOXY}-HEPTANOIC ACID FORMUL 2 PLP C8 H10 N O6 P FORMUL 3 BN2 C21 H21 CL3 N2 O5 FORMUL 4 HOH *240(H2 O) HELIX 1 1 GLY A 20 THR A 38 1 19 HELIX 2 2 THR A 47 ASP A 78 1 32 HELIX 3 3 THR A 94 LEU A 102 1 9 HELIX 4 4 LEU A 104 LEU A 115 1 12 HELIX 5 5 ASP A 118 GLU A 124 1 7 HELIX 6 6 GLY A 134 LEU A 150 1 17 HELIX 7 7 ASP A 251 ASP A 256 1 6 HELIX 8 8 GLY A 261 ASP A 268 1 8 HELIX 9 9 ALA A 272 ARG A 277 5 6 HELIX 10 10 LYS A 289 SER A 314 1 26 HELIX 11 11 ASN A 325 ASP A 327 5 3 HELIX 12 12 ALA A 328 LYS A 332 1 5 HELIX 13 13 LEU A 344 LEU A 356 1 13 HELIX 14 14 ASP A 360 THR A 371 1 12 HELIX 15 15 ILE A 380 LEU A 384 5 5 HELIX 16 16 VAL A 389 LEU A 396 1 8 HELIX 17 17 LEU A 396 PHE A 418 1 23 HELIX 18 18 ASP A 421 SER A 429 1 9 HELIX 19 19 MET A 441 SER A 449 1 9 HELIX 20 20 ALA A 456 THR A 466 1 11 HELIX 21 21 PHE A 468 GLU A 475 1 8 HELIX 22 22 ASN A 496 GLY A 508 1 13 HELIX 23 23 GLU A 509 VAL A 525 5 17 HELIX 24 24 ASP A 527 TYR A 553 1 27 HELIX 25 25 ARG A 575 GLU A 593 1 19 HELIX 26 26 TYR A 613 ASN A 631 1 19 HELIX 27 27 ARG A 649 ILE A 657 1 9 HELIX 28 28 PRO A 658 ALA A 660 5 3 HELIX 29 29 THR A 676 ASN A 684 1 9 HELIX 30 30 ALA A 695 GLY A 704 1 10 HELIX 31 31 GLU A 705 PHE A 708 5 4 HELIX 32 32 ARG A 714 GLY A 725 1 12 HELIX 33 33 ASN A 727 ILE A 735 1 9 HELIX 34 34 ILE A 735 SER A 747 1 13 HELIX 35 35 PHE A 758 HIS A 768 1 11 HELIX 36 36 VAL A 773 ALA A 775 5 3 HELIX 37 37 ASP A 776 LYS A 792 1 17 HELIX 38 38 ASN A 793 ALA A 806 1 14 HELIX 39 39 THR A 807 PHE A 811 5 5 HELIX 40 40 SER A 812 ILE A 824 1 13 SHEET 1 A 3 LYS A 191 ALA A 192 0 SHEET 2 A 3 GLN A 219 PRO A 231 -1 O ASP A 227 N LYS A 191 SHEET 3 A 3 LEU A 198 PHE A 202 -1 N LEU A 198 O ALA A 223 SHEET 1 B 9 LYS A 191 ALA A 192 0 SHEET 2 B 9 GLN A 219 PRO A 231 -1 O ASP A 227 N LYS A 191 SHEET 3 B 9 VAL A 238 LYS A 247 -1 O LYS A 247 N LEU A 222 SHEET 4 B 9 ALA A 154 ILE A 159 1 N GLY A 156 O ARG A 242 SHEET 5 B 9 ARG A 81 LEU A 85 1 N ILE A 82 O TYR A 155 SHEET 6 B 9 VAL A 333 ASN A 338 1 O ALA A 334 N TYR A 83 SHEET 7 B 9 CYS A 372 THR A 375 1 O ALA A 373 N LEU A 337 SHEET 8 B 9 VAL A 452 GLY A 454 1 O ASN A 453 N TYR A 374 SHEET 9 B 9 PHE A 479 ASN A 481 1 O GLN A 480 N VAL A 452 SHEET 1 C 2 PHE A 89 GLY A 92 0 SHEET 2 C 2 ALA A 129 LEU A 131 -1 O LEU A 131 N PHE A 89 SHEET 1 D 2 ASN A 167 CYS A 171 0 SHEET 2 D 2 TRP A 174 GLU A 178 -1 O MET A 176 N LYS A 169 SHEET 1 E 2 ARG A 205 THR A 209 0 SHEET 2 E 2 GLY A 212 VAL A 216 -1 O VAL A 216 N ARG A 205 SHEET 1 F 3 ARG A 386 PRO A 388 0 SHEET 2 F 3 ARG A 438 ASN A 440 -1 O ILE A 439 N TRP A 387 SHEET 3 F 3 VAL A 431 GLU A 432 -1 N GLU A 432 O ARG A 438 SHEET 1 G 6 LEU A 640 LEU A 645 0 SHEET 2 G 6 ARG A 601 GLY A 606 1 N VAL A 603 O ILE A 643 SHEET 3 G 6 LEU A 562 VAL A 567 1 N ASP A 564 O MET A 604 SHEET 4 G 6 LEU A 662 GLN A 665 1 O LEU A 662 N PHE A 563 SHEET 5 G 6 LEU A 687 GLY A 690 1 O LEU A 687 N SER A 663 SHEET 6 G 6 PHE A 709 ILE A 710 1 O PHE A 709 N THR A 688 LINK C4A PLP A 999 NZ LYS A 680 1555 1555 1.33 LINK CA ASN A 44 O4 BN2 A 930 7556 1555 1.87 LINK CB ASN A 44 O4 BN2 A 930 7556 1555 2.00 SITE 1 AC1 15 GLY A 134 LYS A 568 LYS A 574 TYR A 648 SITE 2 AC1 15 ARG A 649 VAL A 650 GLY A 675 THR A 676 SITE 3 AC1 15 GLY A 677 LYS A 680 HOH A1059 HOH A1111 SITE 4 AC1 15 HOH A1112 HOH A1117 HOH A1124 SITE 1 AC2 12 VAL A 40 LYS A 41 ASP A 42 ASN A 44 SITE 2 AC2 12 VAL A 45 TRP A 67 GLN A 71 GLN A 72 SITE 3 AC2 12 TYR A 75 ARG A 193 LYS A 759 HOH A1194 CRYST1 128.679 128.679 115.977 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007771 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007771 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008622 0.00000